UC San Diego Health Now Offering Blood Test for Testicular Cancer
The test measures microRNA-371a-3P biomarker and can guide treatment decisions while reducing need for some CT scans during surveillance.
The test measures microRNA-371a-3P biomarker and can guide treatment decisions while reducing need for some CT scans during surveillance.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The GeneSight test results led to faster initial remission and response in patients with major depressive disorder, with benefits persisting over six months.
The 24- and 48-format carriers join the existing 96-format solution to provide laboratories with scalable tube processing workflows.
Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.